Hamza Suria

2018

In 2018, Hamza Suria earned a total compensation of $5.1M as President, Chief Executive Officer and Director at ANAPTYSBIO, a 28% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$270,765
Option Awards$4,303,927
Salary$547,000
Other$540
Total$5,122,232

Suria received $4.3M in option awards, accounting for 84% of the total pay in 2018.

Suria also received $270.8K in non-equity incentive plan, $547K in salary and $540 in other compensation.

Rankings

In 2018, Hamza Suria's compensation ranked 1,945th out of 14,244 executives tracked by ExecPay. In other words, Suria earned more than 86.3% of executives.

ClassificationRankingPercentile
All
1,945
out of 14,244
86th
Division
Manufacturing
701
out of 5,765
88th
Major group
Chemicals And Allied Products
232
out of 2,128
89th
Industry group
Drugs
184
out of 1,817
90th
Industry
Pharmaceutical Preparations
142
out of 1,391
90th
Source: SEC filing on April 26, 2019.

Suria's colleagues

We found three more compensation records of executives who worked with Hamza Suria at ANAPTYSBIO in 2018.

2018

Marco Londei

ANAPTYSBIO

Chief Medical Officer

2018

Eric Loumeau

ANAPTYSBIO

General Counsel

2018

Dominic Piscitelli

ANAPTYSBIO

Chief Financial Officer

News

In-depth

You may also like